Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
32
MLSS Quote, Financials, Valuation and Earnings
Last price:
$0.26
Seasonality move
:
-8.61%
Day range:
$0.26 - $0.27
52-week range:
$0.22 - $1.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.34x
P/B ratio:
7.95x
Volume:
76.4K
Avg. volume:
233.1K
1-year change:
-76.37%
Market cap:
$20.3M
Revenue:
$8.6M
EPS (TTM):
-$0.08
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MLSS
Milestone Scientific, Inc.
|
$2.3M | -$0.02 | 14.7% | -42.53% | $1.00 |
|
ALGN
Align Technology, Inc.
|
$1B | $2.97 | 4.3% | 78.2% | $198.57 |
|
LANZ
Lancer Orthodontics, Inc.
|
-- | -- | -- | -- | -- |
|
SONX
Sonendo
|
-- | -- | -- | -- | -- |
|
XRAY
Dentsply Sirona, Inc.
|
$926.4M | $0.29 | 1.65% | 250.92% | $13.23 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific, Inc.
|
$0.26 | $1.00 | $20.3M | -- | $0.00 | 0% | 2.34x |
|
ALGN
Align Technology, Inc.
|
$190.02 | $198.57 | $13.6B | 33.58x | $0.00 | 0% | 3.42x |
|
LANZ
Lancer Orthodontics, Inc.
|
$0.0270 | -- | $74.8K | -- | $0.00 | 0% | 0.01x |
|
SONX
Sonendo
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
XRAY
Dentsply Sirona, Inc.
|
$12.54 | $13.23 | $2.5B | -- | $0.16 | 5.1% | 0.69x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MLSS
Milestone Scientific, Inc.
|
29.24% | -0.601 | 2.95% | 0.69x |
|
ALGN
Align Technology, Inc.
|
2% | 1.016 | 0.74% | 1.14x |
|
LANZ
Lancer Orthodontics, Inc.
|
-- | -14.109 | -- | -- |
|
SONX
Sonendo
|
-- | 0.000 | -- | -- |
|
XRAY
Dentsply Sirona, Inc.
|
62.66% | 1.554 | 97.97% | 0.73x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific, Inc.
|
$1.6M | -$1.1M | -125.67% | -142.42% | -48.07% | $75.6K |
|
ALGN
Align Technology, Inc.
|
$688.1M | $159.6M | 10.19% | 10.49% | 15.24% | $223.2M |
|
LANZ
Lancer Orthodontics, Inc.
|
-- | -- | -- | -- | -- | -- |
|
SONX
Sonendo
|
-- | -- | -- | -- | -- | -- |
|
XRAY
Dentsply Sirona, Inc.
|
$441M | $49M | -20.14% | -44.58% | 5.42% | $40M |
Milestone Scientific, Inc. vs. Competitors
-
Which has Higher Returns MLSS or ALGN?
Align Technology, Inc. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of 12.96%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Align Technology, Inc.'s return on equity of 10.49%.
Company Gross Margin Earnings Per Share Invested Capital MLSSMilestone Scientific, Inc.68.68% -$0.01 $3.6M ALGNAlign Technology, Inc.65.69% $1.89 $4.1B -
What do Analysts Say About MLSS or ALGN?
Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 288.2%. On the other hand Align Technology, Inc. has an analysts' consensus of $198.57 which suggests that it could grow by 4.55%. Given that Milestone Scientific, Inc. has higher upside potential than Align Technology, Inc., analysts believe Milestone Scientific, Inc. is more attractive than Align Technology, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLSSMilestone Scientific, Inc.1 0 0 ALGNAlign Technology, Inc.7 8 0 -
Is MLSS or ALGN More Risky?
Milestone Scientific, Inc. has a beta of 0.966, which suggesting that the stock is 3.437% less volatile than S&P 500. In comparison Align Technology, Inc. has a beta of 1.841, suggesting its more volatile than the S&P 500 by 84.113%.
-
Which is a Better Dividend Stock MLSS or ALGN?
Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Align Technology, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLSS or ALGN?
Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Align Technology, Inc. quarterly revenues of $1B. Milestone Scientific, Inc.'s net income of -$1.2M is lower than Align Technology, Inc.'s net income of $135.8M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Align Technology, Inc.'s PE ratio is 33.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.34x versus 3.42x for Align Technology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLSSMilestone Scientific, Inc.2.34x -- $2.4M -$1.2M ALGNAlign Technology, Inc.3.42x 33.58x $1B $135.8M
-
Which has Higher Returns MLSS or LANZ?
Lancer Orthodontics, Inc. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of --. Milestone Scientific, Inc.'s return on equity of -142.42% beat Lancer Orthodontics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MLSSMilestone Scientific, Inc.68.68% -$0.01 $3.6M LANZLancer Orthodontics, Inc.-- -- -- -
What do Analysts Say About MLSS or LANZ?
Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 288.2%. On the other hand Lancer Orthodontics, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Milestone Scientific, Inc. has higher upside potential than Lancer Orthodontics, Inc., analysts believe Milestone Scientific, Inc. is more attractive than Lancer Orthodontics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLSSMilestone Scientific, Inc.1 0 0 LANZLancer Orthodontics, Inc.0 0 0 -
Is MLSS or LANZ More Risky?
Milestone Scientific, Inc. has a beta of 0.966, which suggesting that the stock is 3.437% less volatile than S&P 500. In comparison Lancer Orthodontics, Inc. has a beta of 0.493, suggesting its less volatile than the S&P 500 by 50.668%.
-
Which is a Better Dividend Stock MLSS or LANZ?
Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lancer Orthodontics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Lancer Orthodontics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLSS or LANZ?
Milestone Scientific, Inc. quarterly revenues are $2.4M, which are larger than Lancer Orthodontics, Inc. quarterly revenues of --. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Lancer Orthodontics, Inc.'s net income of --. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Lancer Orthodontics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.34x versus 0.01x for Lancer Orthodontics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLSSMilestone Scientific, Inc.2.34x -- $2.4M -$1.2M LANZLancer Orthodontics, Inc.0.01x -- -- --
-
Which has Higher Returns MLSS or SONX?
Sonendo has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of --. Milestone Scientific, Inc.'s return on equity of -142.42% beat Sonendo's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MLSSMilestone Scientific, Inc.68.68% -$0.01 $3.6M SONXSonendo-- -- -- -
What do Analysts Say About MLSS or SONX?
Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 288.2%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Milestone Scientific, Inc. has higher upside potential than Sonendo, analysts believe Milestone Scientific, Inc. is more attractive than Sonendo.
Company Buy Ratings Hold Ratings Sell Ratings MLSSMilestone Scientific, Inc.1 0 0 SONXSonendo0 0 0 -
Is MLSS or SONX More Risky?
Milestone Scientific, Inc. has a beta of 0.966, which suggesting that the stock is 3.437% less volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MLSS or SONX?
Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLSS or SONX?
Milestone Scientific, Inc. quarterly revenues are $2.4M, which are larger than Sonendo quarterly revenues of --. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Sonendo's net income of --. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.34x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLSSMilestone Scientific, Inc.2.34x -- $2.4M -$1.2M SONXSonendo-- -- -- --
-
Which has Higher Returns MLSS or XRAY?
Dentsply Sirona, Inc. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of -47.35%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.
Company Gross Margin Earnings Per Share Invested Capital MLSSMilestone Scientific, Inc.68.68% -$0.01 $3.6M XRAYDentsply Sirona, Inc.48.78% -$2.14 $4B -
What do Analysts Say About MLSS or XRAY?
Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 288.2%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $13.23 which suggests that it could grow by 5.53%. Given that Milestone Scientific, Inc. has higher upside potential than Dentsply Sirona, Inc., analysts believe Milestone Scientific, Inc. is more attractive than Dentsply Sirona, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLSSMilestone Scientific, Inc.1 0 0 XRAYDentsply Sirona, Inc.2 14 0 -
Is MLSS or XRAY More Risky?
Milestone Scientific, Inc. has a beta of 0.966, which suggesting that the stock is 3.437% less volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 1.012, suggesting its more volatile than the S&P 500 by 1.166%.
-
Which is a Better Dividend Stock MLSS or XRAY?
Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.1% to investors and pays a quarterly dividend of $0.16 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MLSS or XRAY?
Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Dentsply Sirona, Inc. quarterly revenues of $904M. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.34x versus 0.69x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLSSMilestone Scientific, Inc.2.34x -- $2.4M -$1.2M XRAYDentsply Sirona, Inc.0.69x -- $904M -$428M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
